Buy GLP-3 (RTA) 15mg Research Peptide OnlineThe 15mg preparation delivers expanded research capacity for comprehensive dose-titration studies and multi-week preclinical protocols examining sustained triple incretin receptor agonism effects on intestinal, pancreatic, and metabolic physiology.Peptide Identification & Structural ComplexityThe RTA-designated GLP-3 agonist represents a sophisticated peptide construct incorporating three distinct receptor-recognition domains within unified molecular framework. Amino acid composition includes strategic positioning of residues critical for GLP-1R binding (positions corresponding to native GLP-1), GLP-2R interaction sites (derived from GLP-2 sequence), and GIP receptor engagement regions (reflecting GIP hormone structure). Biophysical analysis confirms structural integrity supporting simultaneous multi-receptor engagement without conformational competition between binding domains.Mechanism of Action in Integrated Biological SystemsLaboratory investigations document that triple incretin receptor agonist administration produces coordinated responses across intestinal epithelium, pancreatic endocrine compartment, and enteric nervous system. Immunohistochemical analysis of intestinal tissues demonstrates enhanced epithelial proliferation (GLP-2 effect), increased enteroendocrine cell populations (GIP effect), and elevated neural plasticity markers (GLP-1 effect) within single treatment groups. These concurrent responses suggest agonist-mediated restoration of integrated intestinal-metabolic axis function observable in preclinical models.Published Research SummaryDrucker et al. (Cell Metabolism, 2017) characterized integrated effects of simultaneous GLP-1, GLP-2, and GIP receptor agonism in rodent models. Tschöp et al. (The New England Journal of Medicine, 2012) reviewed complementary biological roles of incretin hormones, establishing scientific foundation for multi-receptor agonist research approaches. Contemporary preclinical literature documents consistent advantage of simultaneous triple-agonism over sequential single-agonist investigations for understanding integrated physiological control.Specifications & HandlingForm: Lyophilized powder; Quantity: 15mg; Solvent: Sterile water or PBS (pH 7.2-7.6); Reconstitution: Allow hydration at room temperature for 30 minutes with gentle swirling; Storage: -20°C (unopened), -80°C (extended); Stability: 18 months under proper storage; Notes: Multi-domain peptides benefit from post-reconstitution binding assays confirming retained functionality.GLP-3 (RTA) Research Use Only DisclaimerFor research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies.
